FDA Inspection
PhytogenX, Inc.PhytogenX, Inc. – FDA Inspection, Feb 10, 2020
Record Details
This FDA Inspection record concerns PhytogenX, Inc., with an inspection on February 10, 2020, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- PhytogenX, Inc.
- Inspection Date
- February 10, 2020
- Product Type
- Drugs
View Company Profile
ID · 09e986c7-c20d-4cb9-b18b-52e14a0ee634
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1117358
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.160(a)Following/documenting laboratory controls
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of PhytogenX, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 27, 2025 | VAI | Philadelphia District Office | Drug Quality Assurance |
| June 6, 2023 | NAI | Center for Food Safety and Applied Nutrition | Colors and Cosmetics Technology |
| February 14, 2019 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| July 31, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 30, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for PhytogenX, Inc.
- FDA Inspection 1265048 - 2025-03-27
- FDA Inspection 1208087 - 2023-06-06
- FDA Inspection 1079308 - 2019-02-14
- FDA Inspection 935526 - 2015-07-31
- FDA Inspection 682008 - 2010-09-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.